Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
DUBLIN, Ohio, Nov. 29 /PRNewswire-FirstCall/ -- Cardinal Health today announced that the U.S. Drug Enforcement Administration (DEA) will temporarily suspend its license to distribute controlled substances from its Auburn, Wash. distribution center effective Dec. 3 .
The company said the suspension affects only the Washington facility and only controlled substance shipments from that facility. Steps are being taken to ensure continuity of service to its customers.
In an order received today, the DEA said Cardinal Health "failed to maintain effective controls against the diversion of a particular controlled substance," and cites the sale of hydrocodone to one pharmacy that allegedly dispensed excessive amounts of the drug based on illegitimate prescriptions from Internet pharmacy web sites.
Cardinal Health said the security of the pharmaceutical supply chain is among its highest priorities, and it will cooperate fully with the DEA to resolve the suspension.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health , Inc. (NYSE: CAH) is an
SOURCE Cardinal Health , Inc.